Cargando…
The use of pharmacogenetic testing in patients with schizophrenia or bipolar disorder: A systematic review
INTRODUCTION: Pharmacogenetic testing may assist in identifying an individual's risk of developing a mental illness as well as predict an individual's response to treatment. The objective of this study is to report published outcomes of pharmacogenetic testing in patients with schizophreni...
Autores principales: | Routhieaux, Melanie, Keels, Jessica, Tillery, Erika E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213894/ https://www.ncbi.nlm.nih.gov/pubmed/30397571 http://dx.doi.org/10.9740/mhc.2018.11.294 |
Ejemplares similares
-
General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder
por: Ware, Kenric, et al.
Publicado: (2016) -
The use of the ketogenic diet in the treatment of psychiatric disorders
por: Tillery, Erika E., et al.
Publicado: (2021) -
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018) -
Mindfulness-Based Treatment for Bipolar Disorder: A Systematic Review of the Literature
por: Bojic, Sanja, et al.
Publicado: (2017) -
Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)